{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02731",
      "entity_text" : "eculizumab",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:1313" ],
      "TissueType" : [ "tissuelist:TS-0549" ]
    }
  },
  "verbose_text" : "Further studies are warranted to elucidate optimal dosing regimens of eculizumab in aHUS patients, and whether dosing regimens can be predicted based on mutational status, eculizumab levels, or other testing.",
  "reading_complete" : "2020-08-03T15:27:10Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T15:26:37Z",
  "trigger" : "levels",
  "evidence" : [ "eculizumab levels" ],
  "pmc_id" : "4974426",
  "score" : 0
}